INHIBRX
Summary
Inhibrx is a clinical-stage biopharmaceutical company focused on developing biologic therapeutics in oncology and orphan diseases.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 1.34 B
Avg. Deal Size£ 1.34 B
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
